BeiGene, Ltd. (SHA:688235)
247.21
+8.21 (3.44%)
Apr 28, 2025, 2:45 PM CST
BeiGene Employees
BeiGene had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
2.53M CNY
Profits / Employee
-427.85K CNY
Market Cap
192.33B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Jiangsu Hengrui Medicine | 20,238 |
Shenzhen Mindray Bio-Medical Electronics | 18,044 |
WuXi AppTec | 39,414 |
Zhangzhou Pientzehuang Pharmaceutical., | 2,789 |
Aier Eye Hospital Group | 36,718 |
Sichuan Biokin Pharmaceutical | 2,086 |
Shanghai United Imaging Healthcare | 7,440 |
Yunnan Baiyao Group Co.,Ltd | 9,277 |
BeiGene News
- 24 days ago - BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit - Benzinga
- 25 days ago - BeiGene slips on decision to halt lung cancer program - Seeking Alpha
- 4 weeks ago - BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer - Business Wire
- 7 weeks ago - China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer - Benzinga
- 7 weeks ago - BeiGene wins FDA nod for Tevimbra in first-line esophageal cancer - Seeking Alpha
- 2 months ago - BeiGene: Q4 Results Impress With Positive Earnings Expected In 2025 - Seeking Alpha
- 2 months ago - Q4 2024 Beigene Ltd Earnings Presentation Transcript - GuruFocus
- 2 months ago - BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript - Seeking Alpha